Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)
| 1.74 Delayed Data As of May 27 |  +0.06 / +3.57%Today’s Change | 1.56 Today|||52-Week Range 6.33 | -55.84% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Coats Lonnel Chief Executive Officer |  Sale | 2/28/2022 | 48,053 | $2.85 | $137.0K | -15.94% |
Wade Jeffrey L President & Chief Financial Officer | Sale | 2/28/2022 | 25,773 | $2.85 | $73.5K | -15.94% |
Main Alan J | Sale | 2/28/2022 | 19,756 | $2.85 | $56.3K | -15.94% |
Crum Brian T General Counsel & Senior Vice President | Sale | 2/28/2022 | 15,059 | $2.85 | $42.9K | -15.94% |
Kassler Taub Kenneth B SVP-Regulatory Affairs & Quality Assurance | Sale | 2/28/2022 | 13,241 | $2.85 | $37.7K | -15.94% |
Seth Kiernan A Chief Commercial Officer & Vice President | Sale | 2/28/2022 | 8,261 | $2.85 | $23.5K | -15.94% |
Alexander Kristen L Vice President-Finance & Accounting | Sale | 2/28/2022 | 3,337 | $2.85 | $9.5K | -15.94% |
Sobecki Christopher J Director |  Gift | 7/01/2021 | 5,700 | $0.00 | $0.00 | -60.09% |
Coats Lonnel Chief Executive Officer | Buy | 2/28/2022 | 79,380 | $0.00 | $0.00 | -15.94% |
Coats Lonnel Chief Executive Officer | Buy | 2/28/2022 | 84,630 | $0.00 | $0.00 | -15.94% |
Page of 4